Clinicopathological conference: Multisystem failure in a child

Academic Emergency Medicine

Volumn 7, Issue 2, 2000, Pages 169-173

  Chan, Lisa ^a,d   Chinnock, Brian ^b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d NONE   (United States)

Author keywords

Kawasaki disease; Staphylococcal infection; Streptococcal infection; Toxic shock syndrome

Indexed keywords

ARTICLE; CHILD; CLINICAL EXAMINATION; HUMAN; LEPTOSPIROSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE ORGAN FAILURE; PATHOLOGY; PRIORITY JOURNAL; TOXIC SHOCK SYNDROME;

EID: 0033952678     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2000.tb00522.x     Document Type: Article

References (28)

1. Drage LA. Life-threatening rashes: dermatologic signs of four infectious diseases. Mayo Clin Proc. 1999; 74:68-72.
2. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol. 1998; 39:383-98.
3. Harwood-Nuss AL, Perry S. Toxic shock syndrome and toxic shock-like syndrome. In: Tintinalli JE, Ruiz E, Krome RL (eds). Emergency Medicine, Fourth Edition. New York: McGraw-Hill, 1996, pp 697-701.
4. Cuttica RJ. Vasculitis in children: a diagnostic challenge. Curr Probl Pediatr. 1997; 27:309-18.
5. Samuel J, O'Sullivan J. Kawasaki disease. Br J Hosp Med. 1996; 55:9-14.
6. Barron KS. Kawasaki disease in children. Curr Opin Rheum. 1998; 10:29-37.
7. Barron KS, Shulman ST, Rowley A, et al: Report of the National Institutes of Health workshop on Kawasaki disease. J Rheum. 1999; 26:170-90.
8. Speck WT, Toltzis P. Leptospirosis. In: Behrman RE, Vaughan VC, Nelson WE (eds). Nelson Textbook of Pediatrics, 13th Edition. Philadelphia: W. B. Saunders, 1987, pp 781-3.
9. Emond RT, Rowland HA, Welsby PD. Color Atlas of Infectious Disease, Third Edition. New York: Mosby-Wolfe, 1995, pp 18-21, 154-9.
10. Hickey SM, Strasburger VC. What every pediatrician should know about infectious mononucleosis in adolescents. Pediatr Clin North Am. 1997; 44:1541-56.
11. Jerrard D. Infectious mononucleosis. In: Harwood-Nuss AL, Linden CH, Luten RC, Shepherd SM, Wolfson AB (eds). The Clinical Practice of Emergency Medicine, Second Edition. New York: Lippincott-Raven, 1996, pp 814-6.
12. Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982; 96:875-80.
13. Fischer P, Uttenreuther-Fischer MM, Naoe S, Gaedicke G. Kawasaki disease: update on diagnosis, treatment, and a still controversial etiology. Pediatr Hematol Oncol. 1996; 13:487-501.
14. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986; 315:341-7.
15. Durongpistkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995; 96:1057-61.
16. Parsonnet J. Nonmenstrual toxic shock syndrome: new insights into diagnosis, pathogenesis, and treatment. Curr Clin Top Infect Dis. 1996; 16:1-20.
17. Scott DF, Best GK, Kling JM, Thompson MR, Adinolfi LE, Bonventre PF. Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1. Rev Infect Dis. 1989; 11(Jan/Feb suppl 1):S214-S218.
18. Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. 1992; 267:3315-6.
19. Dickgiesser N, Wallach U. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations. Infection. 1987; 15:351-3.
20. Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis. 1984; 149:171.
21. Parsonnet J, Modern PA, Giacobbe KD. Effect of subinhibitory concentrations of antibiotics on production of toxic shock syndrome toxin-1 (TSST-1). Presented at the 32nd Annual Meeting of Infectious Diseases Society of America, Orlando, FL, Oct 1994.
22. Wiesenthal A, Todd J. Toxic shock syndrome in children aged 10 years or less. Pediatrics. 1984; 74:112-7.
23. Davies HD, Kirk V, Jadavji T, Kotzin BL. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J. 1996; 15:1136-8.
24. Gamillscheg A, Zobel G, Karpf EF, et al. Atypical presentation of Kawasaki disease in an infant. Pediatr Cardiol. 1993; 14:223-6.
25. Abe J, Kotzin BL, Meissner C, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993; 177:791-6.
26. Choi Y, Lafferty J, Clements J, et al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med. 1990; 172:981-4.
27. Leung DY, Sullivan KE, Brown-Whitehorn TF, et al. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res. 1997; 42:268-72.
28. Terai M, Miwa K, Williams T, et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis. 1995; 172:558-61.